摘要
目的探讨对重症脑血管病患者进行治疗期间早期肠内营养支持的应用价值。方法方便选择该院2015年5月—2017年12月收治的152例重症脑血管病患者作为实验对象;采用数字奇偶法分组;临床给予营养干预期间,对照组(76例):选择肠外营养治疗干预方法;观察组(76例):选择早期肠内营养支持干预方法;最终就两组重症脑血管病患者生化指标以及免疫学指标加以对比。结果同对照组重症脑血管病患者生化指标展开对比,观察组PA(0.26±0.04)g/L、ALB(35.79±3.91)g/L、GLU(10.95±3.22)mmol/L、TG(1.53±1.05)g/L、ALT(40.39±7.19)U/L获得明显改善(t=4.623 3、4.319 3、5.535 0、1.990 3、29.817 1,P<0.05);同对照组重症脑血管病患者免疫学指标展开对比,观察组患者CD3(68.29±5.19)%、Ig A(5.23±0.07)g/L、NK(13.56±1.15)%以及CD4/CD8(1.70±0.21)获得明显改善(t=10.349 5、266.574 6、20.514 8、8.915 6,P<0.05)。结论对于重症脑血管病患者临床给予早期肠内营养支持干预,于患者生化指标以及免疫学指标的改善方面可以获得确切效果,从而促进重症脑血管病患者的病情好转。
Objective This paper tries to explore the application value of early enteral nutrition support during treatment of patients with severe cerebrovascular disease. Methods 152 patients with severe cerebrovascular disease who were admitted to the hospital from May 2015 to December 2017 were selected as experimental subjects; they were grouped using the numerical odds method; during the clinical nutrition intervention, the control group(76 cases): the parenteral nutrition intervention method. The observation group(76 cases): The early enteral nutrition support intervention method was selected; finally, the biochemical and immunological parameters of the two groups of severe cerebrovascular disease patients were compared. Results The biochemical indicators of the patients with severe cerebrovascular disease in the control group were compared. The observation group PA(0.26±0.04) g/L, ALB(35.79±3.91) g/L, GLU(10.95±3.22) mmol/L, TG(1.53±1.05) g/L and ALT(40.39±7.19) U/L were significantly improved(t=4.623 3, 4.319 3, 5.535 0, 1.990 3, 29.817 1, P〈0.05); the immunological parameters of patients with severe cerebrovascular disease in the control group were compared. CD3(68.29 ±5.19)%, IgA(5.23±0.07) g/L, NK(13.56±1.15)%, and CD4/CD8(1.70±0.21) were significantly improved in the observation group(t=10.349 5, 266.574 6, 20.514 8, 8.915 6, P〈0.05). Conclusion The early enteral nutrition support intervention for patients with severe cerebrovascular disease can be used to obtain precise results in the improvement of biochemical indicators and immunological parameters of patients, thereby promoting the improvement of the condition of patients with severe cerebrovascular disease.
作者
任海蓉
REN Hai-rong(Department of Neurology,Ward Three,the Second People's Hospital of Jinzhong,Jinzhong,Shared Province,030800 China)
出处
《中外医疗》
2018年第19期63-65,共3页
China & Foreign Medical Treatment
关键词
早期肠内营养支持
重症脑血管病
临床效果
Early enteral nutrition support
Severe eerebrovaseular disease
Clinical effect